Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 24,546 | 12,123 | 25,619 | 28,570 | 19,112 |
| Operating Income | -24,546 | -12,123 | -25,619 | -28,570 | -19,112 |
| Other Income | -8,124 | 4,474 | 388 | 1,962 | 1,255 |
| Pre-tax Income | -32,670 | -7,649 | -25,231 | -26,608 | -17,857 |
| Net Income Continuous | -32,670 | -7,649 | -25,231 | -26,608 | -17,857 |
| Net Income | $-32,670 | $-7,649 | $-25,231 | $-26,608 | $-17,857 |
| EPS Basic Total Ops | -106.45 | -49.48 | -178.41 | -211.39 | -212.89 |
| EPS Basic Continuous Ops | -106.47 | -49.63 | -178.15 | -211.83 | -212.95 |
| EPS Diluted Total Ops | -106.45 | -49.48 | -178.41 | -211.39 | -212.89 |
| EPS Diluted Continuous Ops | -106.47 | -49.63 | -178.15 | -211.83 | -212.95 |
| EBITDA(a) | $-24,358 | $-11,793 | $-25,231 | $-28,137 | $-18,938 |